McCall Shannon J, Branton Philip A, Blanc Victoria M, Dry Sarah M, Gastier-Foster Julie M, Harrison James H, Jewell Scott D, Dash Rajesh C, Obeng Rebecca C, Rose Joan, Mateski Dawna L, Liubinskas Albi, Robb James A, Ramirez Nilsa C, Shea Kathi
1 Department of Pathology, Duke University Health System , Durham, North Carolina.
2 National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
Biopreserv Biobank. 2018 Feb;16(1):16-22. doi: 10.1089/bio.2017.0108. Epub 2018 Feb 2.
The College of American Pathologists (CAP) developed the Biorepository Accreditation Program (BAP) in 2012. This program integrates best practices from the International Society for Biological and Environmental Biorepositories, the National Cancer Institute, the Organisation for Economic Cooperation and Development, the Center for Medicare and Medicaid Services, and the CAP Laboratory Accreditation Program. The goal of this elective program is to provide requirements for standardization in biorepository processes that will result in high-quality specimens that can be used to support research, drug discovery, and personalized medicine. CAP uses a peer inspection model to ensure the inspectors have proper expertise and to promote educational efforts through information sharing. Lead inspectors are comprised of pathologists, PhDs, and managers of biorepositories and they are often supported by CAP staff inspectors. Accreditation is a 3-year continuous cycle of quality with a peer inspection occurring at the start of year 1 and a self-inspection and CAP desk assessment at the start of year 2 and 3. At this time 53 biorepositories are fully CAP BAP accredited and 13 are in the process of obtaining accreditation. There are currently 273 established standards with requirement lists customized based on the scope of activities performed by a biorepository. A total of 90 inspections were completed between May 2012 and December 2016. Sixty-one were initial inspections and 29 were reinspections. A total of 527 deficiencies were identified in the areas of Equipment/Instrumentation (22%), Information Technology (18%), Specimen Handling and QC (15%), Quality Management (16%), Personnel (11%), Safety (10%), Facilities (6%), and Regulatory (2%). Assessment of common deficiencies identifies areas of focus for continuous improvement and educational opportunities. Overall success of the program is high based on the current enrollment of 66 biorepositories, anecdotal participant feedback and increasing national recognition of the BAP in federal documents.
美国病理学家学会(CAP)于2012年制定了生物样本库认证计划(BAP)。该计划整合了国际生物与环境样本库协会、美国国立癌症研究所、经济合作与发展组织、医疗保险和医疗补助服务中心以及CAP实验室认可计划的最佳实践。这个选修计划的目标是为生物样本库流程的标准化提供要求,从而产生高质量的样本,以支持研究、药物研发和个性化医疗。CAP采用同行检查模式,以确保检查人员具备适当的专业知识,并通过信息共享促进教育工作。首席检查人员由病理学家、博士以及生物样本库管理人员组成,他们通常会得到CAP工作人员检查员的支持。认证是一个为期3年的持续质量周期,在第1年开始时进行同行检查,在第2年和第3年开始时进行自我检查和CAP案头评估。目前有53个生物样本库获得了CAP BAP的全面认证,13个正在申请认证的过程中。目前有273项既定标准,其要求清单根据生物样本库开展的活动范围进行定制。2012年5月至2016年12月期间共完成了90次检查。其中61次是初次检查,29次是重新检查。在设备/仪器(22%)、信息技术(18%)、样本处理与质量控制(15%)、质量管理(16%)、人员(11%)、安全(10%)、设施(6%)和法规(2%)等领域共发现了527项缺陷。对常见缺陷的评估确定了持续改进的重点领域和教育机会。基于目前66个生物样本库的参与情况、参与者的轶事反馈以及联邦文件中对BAP越来越高的全国认可度,该计划总体上非常成功。